Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies Inc. reports strong Q3 performance amidst challenges

Patterson Companies Inc. reported strong performance in the Dental segment but faced challenges in certain product categories. The company is focused on executing its strategy to achieve revenue growth, enhance margin performance, and improve efficiency. Despite macroeconomic challenges, the company expressed confidence in driving enhanced growth, profitability, and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

3D Systems

Henry Schein

Envista Holdings Corp

Procter & Gamble

SmileDirectClub

DENTSPLY SIRONA

Many dentists went out of commission amid the novel coronavirus, but as they open back up, consider these dental stocks to buy. 
The post 7 Dental Stocks to Buy for Long-Term Gains appeared first on InvestorPlace.

7 Dental Stocks to Buy for Long-Term Gains

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Patterson Cos. (PDCO) Right Now?

Patterson Cos. (PDCO) reported earnings 30 days ago.

Patterson Cos. (PDCO) Up 17.2% Since Last Earnings Report: Can It Continue?

Patterson Cos. (PDCO) is at a 52-week high, but can investors hope for more gains in the future?

Patterson Cos. (PDCO) Hits Fresh High: Is There Still Room to Run?

Lowe's

Sportsman's Warehouse Hlds

3 Value Stocks Near 52-Week Highs

ResMed

West Pharmaceutical Services

Backed by an upward trend of share prices and projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.

3 Large-Cap MedTech Stocks to Buy on Northbound Market Trend

Joint

Here are some MedTech stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.

4 Best MedTech Stocks to Combat Coronavirus Crisis on Strong ROE

Dolby Laboratories

HD Supply Hlds

Knoll

Teradyne

So far, earnings has not been as bad as expected. However,  the massive increase in coronavirus cases over the weekend threatens to slowdown the economy this quarter.

Best Stocks To Buy As Markets Begin Earnings Season On A Positive Note

DaVita

Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.

3 Growth-Focused MedTech Stocks to Buy Amid Coronavirus Crisis

Is Patterson Cos. (PDCO) a Great Value Stock Right Now?

Anthem

Laboratory

Here we look at three stocks that investors can add to their watchlist backed by robust long-term prospects.

3 GARP MedTech Stocks to Beat Pandemic-Led Market Volatility

Patterson (PDCO) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Why Patterson (PDCO) Could Be Positioned for a Surge

Quest Diagnostics

Sprouts Farmers Markets

Sleep Number

T-Mobile US

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

5 Stocks With Relative Price Strength to Enhance Your Returns

Cerner

Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.

3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs

As of late, it has definitely been a great time to be an investor in Patterson Companies.

Patterson Companies' Shares March Higher, Can It Continue?

Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for Patterson Cos. (PDCO): Time to Buy?

Hologic

Here are some MedTech stocks which might be a solid investment option post the coronavirus blues.

4 Cheap MedTech Stocks Poised to Beat Industry Post-Pandemic

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q4 2020 Results - Earnings Call Transcript

Patterson Companies' (PDCO) fiscal fourth-quarter results reflect dismal performance by Dental and Animal Health segments.

Patterson Companies (PDCO) Q4 Earnings Top Estimates, Up Y/Y

Patterson Cos. Inc. PDCO, +2.89% said Wednesday it swung to a loss of $608.6 million, or $6.44 a share, in its fiscal fourth quarter to April 25, after earnings of $27.9 million, or 30 cents a share, in the year-earlier period.

Patterson companies swings to loss as COVID-19 disrupts dental market

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal year 2020 and fourth quarter ended April 25, 2020. “The strategies we executed during fiscal 2020 produced accelerating performance through the first 11 months, enabling us to exceed our goals for the year despite the impact of COVID-19, resulting in full fiscal 2020 adjusted earnings growth of 10.7 percent,” said Mark Walchirk, President and CEO of Patterson Companies. “Ou

Patterson Companies Reports Fiscal 2020 Fourth-Quarter and Year-End Operating Results

AmerisourceBergen

Align Technology

Becton, Dickinson and Co.

Cardinal Health

Cooper Companies

McKesson

Near-Term Outlook Bleak for Medical Dental Supplies Industry

AECOM

Allegheny Technologies

Bill.com

BorgWarner

China Unicom

Consolidated Communications Holdings

Everbridge

Focus Financial Partners

ManTech

NetEase

Pool

Pure Storage

Dr. Reddy's Labs

United Natural Foods

Veoneer Inc

Werner Enterprises

Workiva

Woodward

To hear some tell it, bigger is always better on Wall Street.

19 of the Best Stocks You've Never Heard Of

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Earnings Preview: Patterson Cos. (PDCO) Q4 Earnings Expected to Decline

AbbVie

Bunge Global SA

Chevron

DXC Technology

Nu Skin Enterprises

Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum.

8 Safe High-Yield Dividend Stocks Offering 5% or More

News for Patterson Companies Stock (PDCO)